CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-05 | DENYES NANCY General Counsel | Option exercise · Restricted Stock Unit | −2,688 | 5,374 | ||
| 2024-01-05 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2024-01-05 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-05 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-12-12 | Shukla Sanjay President and CEO | Purchase | +12,000 | $1.18 | $14K | 106,173 |
| 2023-12-11 | Shukla Sanjay President and CEO | Purchase | +3,000 | $1.17 | $4K | 94,173 |
| 2023-11-13 | Shukla Sanjay President and CEO | Purchase | +13,578 | $1.11 | $15K | 91,173 |
| 2023-11-10 | Shukla Sanjay President and CEO | Purchase | +1,422 | $1.14 | $2K | 77,595 |
| 2023-07-28 | Shukla Sanjay President and CEO | Purchase | +15,000 | $2.01 | $30K | 76,173 |
| 2023-05-17 | Zaknoen Sara Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-17 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-17 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-17 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Gift | −6,000 | 0 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Gift | +6,000 | 6,000 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-17 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-05-10 | SCHIMMEL PAUL Director | Purchase | +200,000 | $2.25 | $450K | 313,023 |
| 2023-04-26 | Zaknoen Sara Director | Option exercise | +6,000 | 6,000 | ||
| 2023-04-26 | Zaknoen Sara Director | Option exercise · Restricted Stock Unit | −6,000 | 0 |
Page 4 of 15 · 284 trades